as on January 8, 2026 at 2:29 am IST
Day's Low
Day's High
6.45%
Downside
1.18%
Upside
52 Week's Low
52 Week's High
54.82%
Downside
8.72%
Upside
Check Crinetics Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$4.6B
EPS (TTM)
-4.9523
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-16.31
Industry PE ratio
6.7
PEG Ratio
0EBITDA
-474.2M
Revenue (TTM)
1.5M
Profit Margin
0.00%
Return On Equity TTM
-44.42%
Track how Crinetics Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Crinetics Pharmaceuticals Inc in the last 5 years
Lowest (-15.08x)
December 31, 2024
Today (-16.31x)
January 7, 2026
Industry (6.70x)
January 7, 2026
Highest (-5.61x)
December 31, 2022
Today’s Price to Earnings Ratio: -16.31x
Compare market cap, revenue, PE, and other key metrics of Crinetics Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $4.6B | 215.59% | -16.31 | 0.00% | |
| BUY | $37.3B | 414.46% | -16.34 | -264.83% | |
| BUY | $52.6B | 191.54% | 1243.22 | 1.36% | |
| BUY | $115.1B | 101.11% | 31.54 | 31.35% | |
| BUY | $80.9B | 61.38% | 18.28 | 32.13% |
The Crinetics Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Crinetics Pharmaceuticals Inc investment value today
Current value as on today
₹1,12,641
Returns
₹12,641
(+12.64%)
Returns from Crinetics Pharmaceuticals Inc Stock
₹7,932 (+7.93%)
Dollar Returns*
₹4,709 (+4.71%)
Based on 20 analysts
90.00%
Buy
10.00%
Hold
0.00%
Sell
Based on 20 analysts, 90% of analysts recommend a 'BUY' rating for Crinetics Pharmaceuticals Inc. Average target price of $80.21
Get share price movements and forecasts by analysts on Crinetics Pharmaceuticals Inc.
What analysts predicted
33.5%UPSIDE
Target Price
$80.21
Current Price
$53.34
Analyzed by
20 Analysts
Target
$80.21
Crinetics Pharmaceuticals Inc target price $80.21, a slight upside of 33.5% compared to current price of $53.34. According to 20 analysts rating.
Search interest for Crinetics Pharmaceuticals Inc Stock has decreased by -16% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 26 September
Fri, 10:37 PM
-Crinetics Pharmaceuticals stock surges 27.35% after FDA approves Palsonify for acromegaly treatment.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 164.8% return, outperforming this stock by 171.8%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 846.3% return, outperforming this stock by 686.8%
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 1.03M → 143.0K (in $), with an average decrease of 86.1% per quarter
Profit Down
![]()
Netprofit is down for the last 13 quarters, -41.92M → -130.09M (in $), with an average decrease of 10.0% per quarter
Price Dip
![]()
In the last 7 days, CRNX stock has moved down by -1.3%
| Organisation | Crinetics Pharmaceuticals Inc |
| Headquarters | 6055 Lusk Boulevard, San Diego, CA, United States, 92121 |
| Industry | Health Technology |
| CEO | Dr. R. Scott Struthers Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Gayathri Diwakar | Senior Director of Investor Relations |
Ms. Garlan Adams J.D. | Chief Legal Officer & Corporate Secretary |
Ms. Adriana Cabre M.B.A. | Chief Human Resources Officer |
Mr. Kevin Capps | Head of Intellectual Property |
Dr. Stephen F. Betz Ph.D. | Co-Founder & Chief Scientific Officer |
Mr. Jeff E. Knight M.P.H. | Chief Operating Officer |
Dr. Alan S. Krasner M.D. | Chief Endocrinologist |
Mr. Chris Robillard M.B.A. | Chief Business Officer |
Dr. R. Scott Struthers Ph.D. | Founder, President, CEO & Director |
Mr. Tobin C. Schilke | Chief Financial Officer |
Crinetics Pharmaceuticals Inc share price today is $53.34 as on at the close of the market. Crinetics Pharmaceuticals Inc share today touched a day high of $53.97 and a low of $49.9.
Crinetics Pharmaceuticals Inc share touched a 52 week high of $57.99 on and a 52 week low of $24.1 on . Crinetics Pharmaceuticals Inc stock price today i.e. is closed at $53.34,which is 8.02% down from its 52 week high and 121.33% up from its 52 week low.
Crinetics Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Crinetics Pharmaceuticals Inc (CRNX) shares with as little as ₹89.849 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹898.49 in Crinetics Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Crinetics Pharmaceuticals Inc share’s latest price of $53.34 as on January 8, 2026 at 2:29 am IST, you will get 0.1875 shares of Crinetics Pharmaceuticals Inc. Learn more about
fractional shares .
Crinetics Pharmaceuticals Inc stock has given 215.59% share price returns and 22.88% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?